NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NIAID E-212-2022-0-PC-01 NEUTRALIZING ANTIBODIES TO PLASMODIUM FALCIPARUM CIRCUMSPOROZOITE PROTEIN AND THEIR USE PCT PCT PCT/US2023/074791 Pending
NCI E-175-2016-0-AU-01 ANTI-KRAS-G12D T CELL RECEPTORS AU DIV 2023233125 Pending
NCI E-138-2023-0-US-01 A MOLECULAR SCAFFOLD FOR DEPLETING HRPN13 AND A SELECT GROUP OF KEN BOX PROTEINS US 63/539,663 Expired
NCI E-065-2021-0-CA-01 BICISTRONIC CHIMERIC ANTIGEN RECEPTORS DESIGNED TO REDUCE RETROVIRAL RECOMBINATION AND USES THEREOF CA National Stage 3212978 Pending
NCI E-231-2017-0-US-02 IMMUNOTOXINS WITH ALBUMIN BINDING DOMAIN US DIV 18/471,137 Pending
NCI E-028-2015-1-EP-01 Anti-Mutated Kras T Cell Receptors EP DIV 23198524.3 Pending
NCATS E-244-2014-0-JP-02 Small Molecule Inhibitors Of Lactate Dehydrogenase and Methods of Use Thereof JP DIV 2023-135162 Pending
NCI E-065-2021-0-US-02 BICISTRONIC CHIMERIC ANTIGEN RECEPTORS DESIGNED TO REDUCE RETROVIRAL RECOMBINATION AND USES THEREOF US National Stage 18/282,919 Pending
NHLBI E-087-2020-0-US-01 HERV-E ANTIBODIES AND METHODS OF THEIR USE US 63/539,170 Expired
NICHD E-058-2021-0-EP-01 La Protein As A Novel Regulator Of Osteoclastogenesis EP National Stage 22711784.3 Pending
NIAMS E-244-2020-0-EP-01 SINGLE DOMAIN ANTIBODIES THAT NEUTRALIZE SARS-CoV-2 EP National Stage 22708683.2 Abandoned
NHLBI E-056-2021-0-CN-01 A New Molecular Scaffold For Targeting HRpn13 CN National Stage 202280022424.0 Pending
NCI E-111-2021-0-US-02 CANCER VACCINE AND METHOD OF USE THEREOF US National Stage 18/550,895 Pending
NIAID E-219-2023-0-US-01 STABILIZED SPIKE STEM-BASED PAN-BETACORONAVIRUS NANOPARTICLE VACCINES US 63/583,090 Expired
NIAID E-045-2021-0-EP-01 COMPOSITIONS OF MATTER COMPRISING STABILIZED CORONAVIRUS ANTIGENS AND THEIR USE EP National Stage 22709536.1 Pending
NCI E-029-2021-0-EP-01 HLA CLASS I-RESTRICTED T CELL RECEPTORS AGAINST CD22 EP National Stage 22709092.5 Pending
NCATS E-039-2021-0-US-02 METHODS AND SYSTEMS FOR SOLID PHASE EXTRACTION US National Stage 18/550,239 Pending
NIAID E-214-2021-2-EP-01 Self-assembling Nanoparticles Based On Amphiphilic Peptides EP National Stage 22756839.1 Pending
NIAID E-214-2021-2-HK-01 Self-assembling Nanoparticles Based On Amphiphilic Peptides HK EP 62024093381.7 Pending
NCI E-237-2017-2-NZ-04 T CELL RECEPTORS RECOGNIZING MUTATED P53 NZ DIV 803564 Pending
NCI E-237-2017-2-NZ-03 T CELL RECEPTORS RECOGNIZING MUTATED P53 NZ DIV 803561 Pending
NCI E-237-2017-2-NZ-02 T CELL RECEPTORS RECOGNIZING MUTATED P53 NZ DIV 803557 Pending
NCI E-237-2017-2-NZ-01 T CELL RECEPTORS RECOGNIZING MUTATED P53 NZ DIV 803551 Pending
NIAID E-081-2013-4-US-01 PREFUSION RSV F PROTEINS AND THEIR USE US CON 18/464,786 11981707 Issued PDF
NIDDK E-051-2021-0-CN-01 HETEROCYCLIC P2Y14 RECEPTOR ANTAGONISTS CN National Stage 202280020636.5 Abandoned
NIAID E-037-2021-1-KR-11 Antibodies Targeting The Spike Protein Of Coronaviruses KR National Stage 10-2023-7030836 Pending
NCI E-040-2012-0-JP-01 Chimeric Antigen Receptors Targeting B-cell Maturation Antigen JP DIV 2023-146498 Pending
CC E-096-2016-0-US-04 POWERED GAIT ASSISTANCE SYSTEMS US CON 18/243,573 Pending
NIAID E-185-2022-0-PC-01 Engineered SARS-CoV-2 Antibodies With Increased Neutralization Breadth PCT PCT PCT/US2023/073517 Pending
NIAID E-260-2014-0-US-07 RECOMBINANT METAPNEUMOVIRUS F PROTEINS AND THEIR USE US DIV 18/462,340 Pending
NIAID E-102-2022-0-US-01 HUMAN PARAINFLUENZA VIRUS IMMUNOGENIC MOLECULES US 63/580,772 Expired
NICHD E-058-2021-0-AU-01 La Protein As A Novel Regulator Of Osteoclastogenesis AU National Stage 2022230408 Pending
NIAID E-183-2022-0-PC-01 Multi Protein Nanoparticle Monkeypox Vaccine PCT PCT PCT/US2023/031683 Pending
NCATS E-039-2021-0-CA-01 METHODS AND SYSTEMS FOR SOLID PHASE EXTRACTION CA National Stage 3212492 Pending
NCI E-169-2022-0-PC-01 Single Domain Antibodies Targeting HPV E6/E7 Oncogenic Peptide/MHC Complexes PCT PCT PCT/US2023/073144 Pending
NICHD E-058-2021-0-US-02 La Protein As A Novel Regulator Of Osteoclastogenesis US National Stage 18/279,476 Pending
NIAID E-007-2015-0-US-02 CD47-targeted Therapies For The Treatment Of Infectious Disease US CON 18/458,903 Pending
NCI E-064-2021-0-EP-01 Adjuvanted Mucosal Subunit Vaccines For Preventing SARS-CoV-2 Transmission And Infection EP National Stage 22705675.1 Pending
NCI E-181-2017-0-NZ-01 HLA CLASS II-RESTRICTED T CELL RECEPTORS AGAINST MUTATED RAS NZ DIV 803139 Pending
NCI E-237-2023-0-US-01 SCAVENGER RECEPTOR-A1 TARGETED LIPID NANOPARTICLE FOR APC DELIVERY OF
MRNA VACCINES 		US 63/535,215 Expired
NCI E-175-2016-0-HK-01 ANTI-KRAS-G12D T CELL RECEPTORS HK EP 42023078137.9 Pending
NICHD E-058-2021-0-CA-01 La Protein As A Novel Regulator Of Osteoclastogenesis CA National Stage 3211983 Pending
NIAID E-001-2024-1-US-01 Viral Strain Serology Assays US 63/578,685 Expired
NCI E-150-2017-2-US-01 Diagnostic Methods For T Cell Therapy US CON 18/455,033 Pending
NIAID E-205-2024-0-US-01 Human Protective Neutralizing and Non-Neutralizing Antibodies and Their Use Against Influenza Viruses US 63/578,505 Expired
NIAID E-037-2021-1-EP-07 Antibodies Targeting The Spike Protein Of Coronaviruses EP National Stage 22705961.5 Pending
NCI E-494-2013-0-HK-01 Methods of Preparing Anti-human Papillomavirus Antigen T Cells HK EP 42023077832.6 Pending
NIAID E-240-2023-0-PC-01 VACCINES AGAINST CORONAVIRUSES PCT PCT PCT/US2023/030602 Pending
NLM E-111-2016-9-US-03 NOVEL CRISPR ENZYMES AND SYSTEMS US CON 18/235,760 Pending
NCATS E-072-2021-0-US-02 FUNCTIONAL BRAIN REGION-SPECIFIC NEURAL SPHEROIDS AND METHODS OF USE US National Stage 18/547,037 Pending